Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

US Patent 12410418 · Granted Sep 9, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rationally-designed single-chain meganucleases with non-palindromic recognition 2025
Methods for producing a complex transgenic trait locus2025
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Engineered meganucleases that target human mitochondrial genomes2024
Optimized engineered nucleases having specificity for the human T cell receptor 2023
Optimized engineered nucleases having specificity for the human T cell receptor 2023
Polynucleotides encoding optimized engineered meganucleases having specificity f2023
Polynucleotides encoding optimized engineered meganucleases having specificity f2023
Polynucleotides encoding engineered meganucleases having specificity for recogni2023